Lv4
403 积分 2021-03-25 加入
A single-cell map of patients with non-small cell lung cancer harboring rare-driver mutations after anti-PD-1 treatment
9天前
已完结
Adagrasib versus docetaxel in KRASG12C-mutated non-small-cell lung cancer (KRYSTAL-12): a randomised, open-label, phase 3 trial
25天前
已完结
Prognostic value of KRAS G12V mutation in lung adenocarcinoma stratified by stages and radiological features
25天前
已完结
Association Between KRAS Variant Status and Outcomes With First-line Immune Checkpoint Inhibitor–Based Therapy in Patients With Advanced Non–Small-Cell Lung Cancer
25天前
已完结
Decoding the air pollutant–psoriasis axis: A multi-layered systems toxicology investigation
1个月前
已完结
Clinical outcomes with definitive surgery or radiotherapy after neoadjuvant immunochemotherapy in stage II-III NSCLC: Full cohort pragmatic analysis
1个月前
已关闭
Remodeling of T and endothelial cells during total neoadjuvant therapy in rectal cancer
1个月前
已完结
Tumor deposits in the impact of esophageal squamous cell carcinoma prognosis and recurrence: A multicenter retrospective cohort study
2个月前
已完结
Pathologic complete response after neoadjuvant immunochemotherapy: persistent recurrence risk highlights the need for stratified management
2个月前
已完结
Pathological Response and Nodal Status Guide Adjuvant Immunotherapy in NSCLC After Neoadjuvant Chemoimmunotherapy: An Eastern Asian Cohort Study
2个月前
已完结
皖公网安备34019202002308
